Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by Nacetylcysteine.

Autor: Orue, Andrea1, Chavez, Valery1, Strasberg-Rieber, Mary1, Rieber, Manuel1 manuel.rieber@gmail.com
Zdroj: BMC Cancer. 11/18/2016, Vol. 16, p1-16. 16p. 3 Diagrams, 1 Chart, 7 Graphs.
Databáze: Academic Search Ultimate